ArticleGastro hep advances2026
The Clinical Implications of Sex on Waitlist Outcomes in Patients With Acute-on-Chronic Liver Failure.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Previous studies have examined the role of sex in the development and prognosis of acute-on-chronic liver failure (ACLF). To our knowledge, few studies have investigated sex-specific waitlist mortality rates stratified by ACLF grade. This question is significant, as women have historically faced greater barriers to liver transplantation and higher waitlist mortality rates compared to men with chronic liver disease. Therefore, understanding whether these disparities persist in ACLF-a condition with intermediate to high acuity-is essential for optimizing patient care and outcomes. Methods: The study population was identified using United Network for Organ Sharing transplant data from 2005 to 2019 and included adult patients registered for liver transplantation. Candidates were stratified by ACLF grade at the time of waitlist registration and further stratified by sex. The primary outcomes were waitlist mortality and liver transplantation, analyzed using a competing-risk regression model to account for transplantation as a competing event. Secondary outcomes included cause-specific mortality, which was evaluated using cause-specific Cox proportional hazards models. Results: In the fully adjusted competing-risk regression model, male sex was associated with lower waitlist mortality among candidates without ACLF (subdistribution hazard ratio [SHR]: 0.87; 95% confidence interval [CI]: 0.83-0.90), ACLF grade 1 (SHR: 0.83; 95% CI: 0.73-0.95), and ACLF grade 2 (SHR: 0.81; 95% CI: 0.70-0.95), while no statistically significant difference was observed in ACLF grade 3 (SHR: 0.92; 95% CI: 0.80-1.06). Male sex was associated with higher liver transplantation rates across all ACLF strata. Conclusion: Competing risk analysis demonstrated higher waitlist mortality among women than men in ACLF grades 1 and 2, potentially reflecting delayed transplant prioritization among female candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.